Skye Bioscience, Inc. (SKYE) stock
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.00−0.06 (-6.10%)
Close on Nov 17, 2026Market cap $35.42MP/E –Yield –
Skye Bioscience total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Skye Bioscience's total debt was $71.10K at Sep 30, 2020.
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $71.10K | – |
| Q2 FY2020 | Jun 30, 2020 | $51.65K | – |
See a number that looks wrong?